Given its role in nucleotide metabolism, HPRT is an attractive target for cancer therapy. Inhibitors of HPRT could potentially disrupt the nucleotide balance in cancer cells, leading to cell death. Additionally, HPRT-deficient cells are sensitive to certain chemotherapeutic agents, making it a potential marker for personalized treatment strategies.
